Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
WCG Clinical | Insights
Should Consent Form updates be aligned with Investigator Brochure updates, or wait for next Protocol amendment?
Blog Posts
WCG Clinical | Insights
What are the Blood Draw Guidelines for Phase 1 Clinical Trials?
Blog Posts
WCG Clinical | Insights
Guidance on genomic research with deceased patients
Blog Posts
WCG Clinical | Insights
If a Subject’s Care Is Divided Equally Between Two Caregivers, Who Should Sign Caregiver Consent?
Blog Posts
WCG Clinical | Insights
Can we charge a subject for a diagnostic test not done as part of the IRB approved protocol?
Blog Posts
WCG Clinical | Insights
How should a site document a missing signature on a HIPAA authorization form?
Blog Posts
WCG Clinical | Insights
What are the IRB Reporting Requirements for Adverse Events?
Blog Posts
WCG Clinical | Insights
Do we need to submit safety events from another site to our IRB?
Blog Posts
WCG Clinical | Insights
How should we handle financial conflicts of interest in FDA-regulated clinical trials?
Blog Posts
WCG Clinical | Insights